Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Efficacy-Based Perspective to Overcome Reduced Opioid Analgesia of Advanced Painful Diabetic Neuropathy in Rats.

Balogh M, Zádor F, Zádori ZS, Shaqura M, Király K, Mohammadzadeh A, Varga B, Lázár B, Mousa SA, Hosztafi S, Riba P, Benyhe S, Gyires K, Schäfer M, Fürst S, Al-Khrasani M.

Front Pharmacol. 2019 Apr 9;10:347. doi: 10.3389/fphar.2019.00347. eCollection 2019.

2.

Chemically Modified Derivatives of the Activator Compound Cloxyquin Exert Inhibitory Effect on TRESK (K2P18.1) Background Potassium Channel.

Lengyel M, Erdélyi F, Pergel E, Bálint-Polonka Á, Dobolyi A, Bozsaki P, Dux M, Király K, Hegedűs T, Czirják G, Mátyus P, Enyedi P.

Mol Pharmacol. 2019 Jun;95(6):652-660. doi: 10.1124/mol.118.115626. Epub 2019 Apr 12.

PMID:
30979812
3.

Similarity and dissimilarity in antinociceptive effects of dipeptidyl-peptidase 4 inhibitors, Diprotin A and vildagliptin in rat inflammatory pain models following spinal administration.

Balogh M, Varga BK, Karádi DÁ, Riba P, Puskár Z, Kozsurek M, Al-Khrasani M, Király K.

Brain Res Bull. 2019 Apr;147:78-85. doi: 10.1016/j.brainresbull.2019.02.001. Epub 2019 Feb 7.

PMID:
30738866
4.

Introducing the craniocervical Y-ligament.

Bodon G, Kiraly K, Tunyogi-Csapo M, Hirt B, Wilke HJ, Harms J, Patonay L.

Surg Radiol Anat. 2019 Feb;41(2):197-202. doi: 10.1007/s00276-018-2116-z. Epub 2018 Oct 15.

PMID:
30324218
5.

Selegiline reduces adiposity induced by high-fat, high-sucrose diet in male rats.

Nagy CT, Koncsos G, Varga ZV, Baranyai T, Tuza S, Kassai F, Ernyey AJ, Gyertyán I, Király K, Oláh A, Radovits T, Merkely B, Bukosza N, Szénási G, Hamar P, Mathé D, Szigeti K, Pelyhe C, Jelemenský M, Onódi Z, Helyes Z, Schulz R, Giricz Z, Ferdinandy P.

Br J Pharmacol. 2018 Sep;175(18):3713-3726. doi: 10.1111/bph.14437. Epub 2018 Aug 7.

PMID:
29971762
6.

Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain.

Király K, Kozsurek M, Lukácsi E, Barta B, Alpár A, Balázsa T, Fekete C, Szabon J, Helyes Z, Bölcskei K, Tékus V, Tóth ZE, Pap K, Gerber G, Puskár Z.

Sci Rep. 2018 Feb 22;8(1):3490. doi: 10.1038/s41598-018-21799-8.

7.

14-O-Methylmorphine: A Novel Selective Mu-Opioid Receptor Agonist with High Efficacy and Affinity.

Zádor F, Balogh M, Váradi A, Zádori ZS, Király K, Szűcs E, Varga B, Lázár B, Hosztafi S, Riba P, Benyhe S, Fürst S, Al-Khrasani M.

Eur J Pharmacol. 2017 Nov 5;814:264-273. doi: 10.1016/j.ejphar.2017.08.034. Epub 2017 Aug 30.

PMID:
28864212
8.

New opioid receptor antagonist: Naltrexone-14-O-sulfate synthesis and pharmacology.

Zádor F, Király K, Váradi A, Balogh M, Fehér Á, Kocsis D, Erdei AI, Lackó E, Zádori ZS, Hosztafi S, Noszál B, Riba P, Benyhe S, Fürst S, Al-Khrasani M.

Eur J Pharmacol. 2017 Aug 15;809:111-121. doi: 10.1016/j.ejphar.2017.05.024. Epub 2017 May 11.

PMID:
28502630
9.

New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration.

Lackó E, Riba P, Giricz Z, Váradi A, Cornic L, Balogh M, Király K, Csekő K, Mousa SA, Hosztafi S, Schäfer M, Zádori ZS, Helyes Z, Ferdinandy P, Fürst S, Al-Khrasani M.

J Pharmacol Exp Ther. 2016 Oct;359(1):171-81. doi: 10.1124/jpet.116.233551. Epub 2016 Jul 19.

PMID:
27435180
10.

A new potent analgesic agent with reduced liability to produce morphine tolerance.

Kiraly K, Caputi FF, Hanuska A, Kató E, Balogh M, Köles L, Palmisano M, Riba P, Hosztafi S, Romualdi P, Candeletti S, Ferdinandy P, Fürst S, Al-Khrasani M.

Brain Res Bull. 2015 Aug;117:32-8. doi: 10.1016/j.brainresbull.2015.07.005. Epub 2015 Jul 30.

PMID:
26235542
11.

Central P2Y12 receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents.

Horváth G, Gölöncsér F, Csölle C, Király K, Andó RD, Baranyi M, Koványi B, Máté Z, Hoffmann K, Algaier I, Baqi Y, Müller CE, Von Kügelgen I, Sperlágh B.

Neurobiol Dis. 2014 Oct;70:162-78. doi: 10.1016/j.nbd.2014.06.011. Epub 2014 Jun 25.

12.

[Behavioural studies during the gestational-lactation period in morphine treated rats].

Sobor M, Timár J, Riba P, Király KP, Al-Khrasani M, Gyarmati Z, Fürst Z.

Neuropsychopharmacol Hung. 2013 Dec;15(4):239-51. Hungarian.

13.

iPhone apps for heterozygous familial hypercholesterolemia.

Thomas IG, Kiraly KJ, Thomas GS.

J Clin Lipidol. 2013 Nov-Dec;7(6):689. doi: 10.1016/j.jacl.2013.07.002. Epub 2013 Sep 3. No abstract available.

PMID:
24314369
14.

Probabilistic sequence learning in mild cognitive impairment.

Nemeth D, Janacsek K, Király K, Londe Z, Németh K, Fazekas K, Adám I, Elemérné K, Csányi A.

Front Hum Neurosci. 2013 Jul 1;7:318. doi: 10.3389/fnhum.2013.00318. eCollection 2013.

15.

Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.

Szentirmay AK, Király KP, Lenkey N, Lackó E, Al-Khrasani M, Friedmann T, Timár J, Gyarmati S, Tóth G, Fürst S, Riba P.

Brain Res Bull. 2013 Jan;90:66-71. doi: 10.1016/j.brainresbull.2012.09.006. Epub 2012 Sep 17.

PMID:
22995282
16.

The central versus peripheral antinociceptive effects of μ-opioid receptor agonists in the new model of rat visceral pain.

Al-Khrasani M, Lackó E, Riba P, Király K, Sobor M, Timár J, Mousa S, Schäfer M, Fürst S.

Brain Res Bull. 2012 Feb 10;87(2-3):238-43. doi: 10.1016/j.brainresbull.2011.10.018. Epub 2011 Nov 6.

PMID:
22079588
17.

Synthesis and pharmacological activities of 6-glycine substituted 14-phenylpropoxymorphinans, a novel class of opioids with high opioid receptor affinities and antinociceptive potencies.

Spetea M, Windisch P, Guo Y, Bileviciute-Ljungar I, Schütz J, Asim MF, Berzetei-Gurske IP, Riba P, Kiraly K, Fürst S, Al-Khrasani M, Schmidhammer H.

J Med Chem. 2011 Feb 24;54(4):980-8. doi: 10.1021/jm101211p. Epub 2011 Jan 14.

18.

The dipeptidyl peptidase IV (CD26, EC 3.4.14.5) inhibitor vildagliptin is a potent antihyperalgesic in rats by promoting endomorphin-2 generation in the spinal cord.

Király K, Lambeir AM, Szalai J, Szentirmay A, Luyten W, Barna I, Puskár Z, Kozsurek M, Rónai AZ.

Eur J Pharmacol. 2011 Jan 10;650(1):195-9. doi: 10.1016/j.ejphar.2010.09.060. Epub 2010 Oct 15.

PMID:
20940010
19.

Effects of opioid agonist and antagonist in dams exposed to morphine during the perinatal period.

Sobor M, Timár J, Riba P, Friedmann T, Király KP, Gyarmati S, Al-Khrasani M, Fürst S.

Brain Res Bull. 2011 Jan 15;84(1):53-60. doi: 10.1016/j.brainresbull.2010.10.001. Epub 2010 Oct 8.

PMID:
20934489
20.

Does the effect of morphine challenge change on maternal behaviour of dams chronically treated with morphine during gestation and further on during lactation?

Sobor M, Timár J, Riba P, Király KP, Gyarmati S, Al-Khrasani M, Fürst S.

Pharmacol Biochem Behav. 2010 May;95(3):367-74. doi: 10.1016/j.pbb.2010.02.015. Epub 2010 Mar 1.

PMID:
20193708
21.

Peri, pre and postnatal morphine exposure: exposure-induced effects and sex differences in the behavioural consequences in rat offspring.

Timár J, Sobor M, Király KP, Gyarmati S, Riba P, Al-Khrasani M, Fürst S.

Behav Pharmacol. 2010 Feb;21(1):58-68. doi: 10.1097/FBP.0b013e3283359f39.

PMID:
20038835
22.

Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value.

Riba P, Friedmann T, Király KP, Al-Khrasani M, Sobor M, Asim MF, Spetea M, Schmidhammer H, Furst S.

Brain Res Bull. 2010 Jan 15;81(1):178-84. doi: 10.1016/j.brainresbull.2009.09.011.

PMID:
19800397
23.

Intrathecally injected Ile-Pro-Ile, an inhibitor of membrane ectoenzyme dipeptidyl peptidase IV, is antihyperalgesic in rats by switching the enzyme from hydrolase to synthase functional mode to generate endomorphin 2.

Király K, Szalay B, Szalai J, Barna I, Gyires K, Verbeken M, Rónai AZ.

Eur J Pharmacol. 2009 Oct 12;620(1-3):21-6. doi: 10.1016/j.ejphar.2009.08.018. Epub 2009 Aug 18.

PMID:
19695241
24.

Immunoreactive endomorphin 2 is generated extracellularly in rat isolated L4,5 dorsal root ganglia by DPP-IV.

Rónai AZ, Király K, Szebeni A, Szemenyei E, Prohászka Z, Darula Z, Tóth G, Till I, Szalay B, Kató E, Barna I.

Regul Pept. 2009 Oct 9;157(1-3):1-2. doi: 10.1016/j.regpep.2009.06.006. Epub 2009 Jun 21.

PMID:
19540879
25.

Nocistatin and nociceptin given centrally induce opioid-mediated gastric mucosal protection.

Zádori ZS, Shujaa N, Köles L, Király KP, Tekes K, Gyires K.

Peptides. 2008 Dec;29(12):2257-65. doi: 10.1016/j.peptides.2008.09.012. Epub 2008 Sep 26.

PMID:
18930088
26.
27.

Alterations in prodynorphin gene expression and dynorphin levels in different brain regions after chronic administration of 14-methoxymetopon and oxycodone-6-oxime.

Király KP, Riba P, D'Addario C, Di Benedetto M, Landuzzi D, Candeletti S, Romualdi P, Furst S.

Brain Res Bull. 2006 Jul 31;70(3):233-9. Epub 2006 Jun 2.

PMID:
16861108
28.

The progression of burn depth in experimental burns: a histological and methodological study.

Papp A, Kiraly K, Härmä M, Lahtinen T, Uusaro A, Alhava E.

Burns. 2004 Nov;30(7):684-90.

PMID:
15475143
29.

Age matters: collagen birefringence of superficial articular cartilage is increased in young guinea-pigs but decreased in older animals after identical physiological type of joint loading.

Hyttinen MM, Arokoski JP, Parkkinen JJ, Lammi MJ, Lapveteläinen T, Mauranen K, Király K, Tammi MI, Helminen HJ.

Osteoarthritis Cartilage. 2001 Nov;9(8):694-701.

30.

Effects of intra-articular injections of bufexamac suspension in healthy horses.

Suominen MM, Tulamo RM, Anttila MO, Sankari SM, Király K, Lapveteläinen T, Helminen HJ.

Am J Vet Res. 2001 Oct;62(10):1629-35.

PMID:
11592331
31.

Expression and prognostic value of alpha-, beta-, and gamma-catenins indifferentiated thyroid carcinoma.

Böhm J, Niskanen L, Kiraly K, Kellokoski J, Eskelinen M, Hollmen S, Alhava E, Kosma VM.

J Clin Endocrinol Metab. 2000 Dec;85(12):4806-11.

PMID:
11134147
32.

Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma.

Böhm JP, Niskanen LK, Pirinen RT, Kiraly K, Kellokoski JK, Moisio KI, Eskelinen MJ, Tulla HE, Hollmen S, Alhava EM, Kosma VM.

J Pathol. 2000 Nov;192(3):321-7.

PMID:
11054715
34.

Articular cartilage collagen birefringence is altered concurrent with changes in proteoglycan synthesis during dynamic in vitro loading.

Király K, Hyttinen MM, Parkkinen JJ, Arokoski JA, Lapveteläinen T, Törrönen K, Kiviranta I, Helminen HJ.

Anat Rec. 1998 May;251(1):28-36.

35.

Specimen preparation and quantification of collagen birefringence in unstained sections of articular cartilage using image analysis and polarizing light microscopy.

Király K, Hyttinen MM, Lapveteläinen T, Elo M, Kiviranta I, Dobai J, Módis L, Helminen HJ, Arokoski JP.

Histochem J. 1997 Apr;29(4):317-27.

PMID:
9184847
36.

Training a large number of laboratory mice using running wheels and analyzing running behavior by use of a computer-assisted system.

Lapveteläinen T, Tiihonen A, Koskela P, Nevalainen T, Lindblom J, Király K, Halonen P, Helminen HJ.

Lab Anim Sci. 1997 Apr;47(2):172-9.

PMID:
9150497
37.

Application of selected cationic dyes for the semiquantitative estimation of glycosaminoglycans in histological sections of articular cartilage by microspectrophotometry.

Király K, Lapveteläinen T, Arokoski J, Törrönen K, Módis L, Kiviranta I, Helminen HJ.

Histochem J. 1996 Aug;28(8):577-90.

PMID:
8894661
38.

Safranin O reduces loss of glycosaminoglycans from bovine articular cartilage during histological specimen preparation.

Király K, Lammi M, Arokoski J, Lapveteläinen T, Tammi M, Helminen H, Kiviranta I.

Histochem J. 1996 Feb;28(2):99-107.

PMID:
8737291
39.

Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone.

Li SW, Prockop DJ, Helminen H, Fässler R, Lapveteläinen T, Kiraly K, Peltarri A, Arokoski J, Lui H, Arita M, et al.

Genes Dev. 1995 Nov 15;9(22):2821-30.

40.

Lifelong moderate running training increases the incidence and severity of osteoarthritis in the knee joint of C57BL mice.

Lapveteläinen T, Nevalainen T, Parkkinen JJ, Arokoski J, Kiraly K, Hyttinen M, Halonen P, Helminen HJ.

Anat Rec. 1995 Jun;242(2):159-65.

PMID:
7668400
41.

An inbred line of transgenic mice expressing an internally deleted gene for type II procollagen (COL2A1). Young mice have a variable phenotype of a chondrodysplasia and older mice have osteoarthritic changes in joints.

Helminen HJ, Kiraly K, Pelttari A, Tammi MI, Vandenberg P, Pereira R, Dhulipala R, Khillan JS, Ala-Kokko L, Hume EL, et al.

J Clin Invest. 1993 Aug;92(2):582-95.

42.

R-plasmid study of an outbreak caused by multiresistant strains of Salmonella panama.

Lantos J, Fekete J, Király K.

Acta Microbiol Acad Sci Hung. 1981;28(3):211-7.

PMID:
7030009
43.

[Comparative studies of Mycosolon, miconazole and depersolone ointments in a double-blind test].

Török I, Várkonyi V, Podányi B, Soós G, Dénes M, Király K.

Dermatol Monatsschr. 1979 Nov;165(11):788-94. German. No abstract available.

PMID:
160874
44.

[Model for the objective evaluation of antimycotic topical agents].

Török I, Soós G, Podányi B, Várkonyi V, Király K.

Dermatol Monatsschr. 1979 Nov;165(11):783-7. German. No abstract available.

PMID:
160873
45.

[Histological and immunohistological studies of urticariform skin manifestations in systemic lupus erythematosus].

Krámer M, Horváth A, Vajda T, Ablonczy E, Király K.

Orv Hetil. 1979 Jul 22;120(29):1737-9. Hungarian. No abstract available.

PMID:
481877
46.

A new method for obtaining viable cells from dermal infiltrates. A study on 2,4 dinitrochlorobenzene induced contact dermatitis.

Molnár L, Baló-Banga JM, Leibinger J, Király K.

Arch Dermatol Res. 1979 Mar 31;264(2):213-23.

PMID:
223502
47.

Isomorphic skin reaction with DNCB in SLE and DLE.

Temesvári E, Horváth A, Krámer M, Ablonczy E, Király K.

Contact Dermatitis. 1979 Mar;5(2):85-9.

PMID:
467031
48.

[Measuring the effectiveness of corticoid externs on eczema models].

Soós G, Temesvári E, Király K.

Acta Pharm Hung. 1979 Jan;49(1):43-7. Hungarian. No abstract available.

PMID:
425842
49.

Effect of KCN on the motility of Treponema pallidium.

Horváth I, Király K, Marschalkó M.

Acta Microbiol Acad Sci Hung. 1979;26(4):273-5.

PMID:
232617

Supplemental Content

Loading ...
Support Center